Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2025-12-30 @ 11:52 AM
Study NCT ID:
NCT04743661
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-08-06
First Post:
2021-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Sponsor:
Pediatric Brain Tumor Consortium
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
PBTC-058
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None